Subacute toxicity and stability of Soshiho-tang, a traditional herbal formula, in Sprague-Dawley rats

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Shin, In Sik ^a   Lee, Mee Young ^a   Kim, Yongbum ^b   Seo, Chang Seob ^a   Kim, Jung Hun ^a   Shin, Hyeun Kyoo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Korea Institute of Toxicology   (South Korea)

Author keywords

Herbal formula; Rat; Soshiho tang; Stability; Toxicity

Indexed keywords

BAICALIN; CHINESE DRUG; GLYCYRRHIZIC ACID; LIQUIRITIN; SOSHIHO TANG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD CHEMISTRY; BODY WEIGHT; CHEMICAL COMPOSITION; CHINESE MEDICINE; CHRONIC LIVER DISEASE; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; FEEDING; FEMALE; FOOD INTAKE; HEMATOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MALE; MORTALITY; NONHUMAN; OPHTHALMOSCOPY; ORGAN WEIGHT; RAT; SALIVATION; TREATMENT DURATION; URINALYSIS; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; DRUGS, CHINESE HERBAL; EATING; FEMALE; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84871601209     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-266     Document Type: Article

References (30)

1. Basch EM, Servoss JC, Tedrow UB. Safety assurances for dietary supplements policy issues and new research paradigms. J Herb Pharmacother 2005, 5:3-15.
2. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 2008, 23:854-859. 10.1007/s11606-008-0632-y, 2517879, 18415652.
3. Ha H, Lee JK, Lee HY, Seo CS, Lee MY, Huh JI, Shin HK. Genotoxicity assessment of a herbal formula, Ojeok-san. J Ethnopharmacol 2011, 135:586-589. 10.1016/j.jep.2011.03.024, 21419208.
4. Shin IS, Yu YB, Seo CS, Ha HK, Lee MY, Huang DS, Kim JH, Shin HK. Subchronic toxicity of Sipjeondaebo-tang (SDT) in Sprague-Dawley Rats. Regul Toxicol Pharmacol 2011, 59:375-384. 10.1016/j.yrtph.2010.09.018, 20937344.
5. Kusunose M, Qiu B, Cui T, Hamada A, Yoshioka S, Ono M, Miyamura M, Kyotani S, Nishioka Y. Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats. Biol Pharm Bull 2002, 25:1417-1421. 10.1248/bpb.25.1417, 12419951.
6. Shiota G, Maeta Y, Mukoyama T, Yanagidani A, Udagawa A, Oyama K, Yashima K, Kishimoto Y, Nakai Y, Miura T, Ito H, Murawaki Y, Kawasaki H. Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2′-deoxyguanosine formation. Hepatology 2002, 35:1125-1133. 10.1053/jhep.2002.33066, 11981762.
7. Chen MH, Chen JC, Tsai CC, Wang WC, Chang DC, Tu DG, Hsiesh HY. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model. J Ethnopharmacol 2005, 97:7-13. 10.1016/j.jep.2004.09.040, 15652268.
8. Taira Z, Yabe K, Hamaguchi Y, Hirayama K, Kishimoto M, Ishida S, Ueda Y. Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats. Food Chem Toxicol 2004, 42:803-807. 10.1016/j.fct.2003.12.017, 15046826.
9. Chen MH, Chen JC, Tsai CC, Wang WC, Chang DC, Lin CC, Hsieh HY. Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats. Am J Chin Med 2004, 32:195-207. 10.1142/S0192415X04001862, 15315258.
10. Zhu K, Fukasawa I, Furuno M. Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Cynecol Oncol 2005, 97:405-409.
11. Yamashiki M, Nishimura A, Nobori T, Nakabayashi S, Takagi T, Inoue K, Ito M. In vitro effects of sho-saiko-to on production of granulocyte colony-stimulating factor by mononuclear cells from patients with chronic hepatitis C. Int J Immunopharmacol 1997, 19:381-385. 10.1016/S0192-0561(97)00064-7, 9568542.
12. Ohtake N, Yamamoto M, Takeda S, Aburada M, Ishige A, Watanabe K, Inoue M. The herbal Medicine Sho-saiko-to selectively inhibits CD8+ T-cell proliferation. Eur J Pharmacol 2005, 507:301-310. 10.1016/j.ejphar.2004.11.037, 15659321.
13. Chang JS, Wang KC, Liu HW, Chen MC, Chiang LC, Lin CC. Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line. Am J Chin Med 2007, 35:341-351. 10.1142/S0192415X07004862, 17436373.
14. Lee JK, Kim JH, Shin HK. Therapeutic effects of the oriental herbal medicine Sho-saiko-to on liver cirrhosis and carcinoma. Hepatol Res 2011, 41:825-837. 10.1111/j.1872-034X.2011.00829.x, 21682829.
15. Timmermans S, Mauck A. The promises and pitfalls of evidence-based medicine. Health Aff (Millwood) 2005, 24:18-28.
16. Eddy DM. Evidence-based medicine: a unified approach. Health Aff (Millwood) 2005, 24:9-17.
17. Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet 2008, 372:1938-1940. 10.1016/S0140-6736(08)61354-9, 18930523.
18. Kang BH, Kim YB, Lee HS, Kim YH, Im WJ, Ha CS. Background data on hematology, blood, biochemistry and organ weights for 2 weeks and 4 weeks repeated dose toxicity studies using Sprague-Dawley (SD) rat. Lab Anim Res 2004, 20:134-140.
19. Michael JD. The toxicologist pocket handbook 2008, USA: Informa Healthcare, CRC press.
20. Nishimori F, Yamazaki K, Jin Y, Yoshimura N, Tsukimoto K, Beppu H, Ichioka M, Yoshizawa Y. Pneumonitis induced by the drug ougon. Nihon Kokyuki Gakkai Zasshi 1999, 37:396-400.
21. Ishizaki T, Sasaki F, Ameshima S, Shiozaki K, Takahashi H, Abe Y, Ito S, Kuriyama M, Nakai T, Kitagawa M. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J 1996, 9:2691-2696. 10.1183/09031936.96.09122691, 8980988.
22. Nakagawa A, Yamaguchi T, Takao T, Amano H. Five cases of drug-induced pneumonitis due to Sho-saiko-to or interferone-alpha or both. Nihon Kyobu Shikkan Gakkai Zasshi 1995, 33:1361-1366.
23. Chen WC, Kuo TH, Tzeng YS, Tsai YC. Baicalin induces apoptosis in SW620 human colorectal carcinoma cells in vitro and suppresses tumor growth in vivo. Molecules 2012, 29:3844-3857.
24. Guan Y, Li FF, Hong L, Yan XF, Tan GL, He JS, Dong XW, Bao MJ, Xie QM. Protective effects of liquiritin apioside on cigarette smoke-induced lung epithelial cell injury. Fundam Clin Pharmacol 2012, 26:473-483. 10.1111/j.1472-8206.2011.00956.x, 21631586.
25. Li XL, Zhou AG, Zhang L, Chen WJ. Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice. Int J Mol Sci 2011, 12:905-916. 10.3390/ijms12020905, 3083680, 21541033.
26. Xie Y, Lu W, Cao S, Jiang X, Yin M, Tang W. Preparation of bupleurum nasal spray and evaluation on its safety and efficacy. Chem Pharm Bull 2006, 54:48-53. 10.1248/cpb.54.48, 16394548.
27. Yimam M, Zhao Y, Ma W, Jia Q, Do SG, Shim JH. 90-day oral toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in rats. Food Chem Toxicol 2010, 48:1202-1209. 10.1016/j.fct.2010.02.011, 20171255.
28. National Toxicology Program Toxicology and carcinogenesis studies of ginseng (CAS No. 50647-08-0) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 2011, 567:1-149. National Toxicology Program.
29. van Miert, ASJPAM The use in animals of drugs licensed for human use only. Comparative Veterinary Pharmacology, Toxicology and Therapy 1986, 489-500. Boston: MTP press, van Miert, ASJPAM.
30. Manimaran A, Sarkar SN, Sankar P. Toxicodynamics of subacute co-exposure to groundwater contaminant arsenic and analgesic-antipyretic drug acetaminophen in rats. Ecotoxicol Environ Safety 2010, 73:94-100. 10.1016/j.ecoenv.2009.09.005, 19782400.